BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
3 hedge funds and large institutions have $7K invested in BIMI International Medical Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
75% more capital invested
Capital invested by funds: $4K → $7K (+$3K)
50% more funds holding
Funds holding: 2 → 3 (+1)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
+$3.92K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.23K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.6K |
BIMI Hedge Fund Activity: Q2 2015 in Review
3 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q2 2015, worth a combined $7K — up 75% from $4K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIMI positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Citigroup, opening a new position worth an estimated $3.92K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.6K.
- 3 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q2 2015, up from 2 in Q1 2015.
- Funds reported $7K of BIMI International Medical Inc. Common Stock stock for Q2 2015, up 75% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q2 2015 and 0 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q2 2015 was Citigroup, an estimated $3.92K added.
- The largest BIMI International Medical Inc. Common Stock seller in Q2 2015 was Tower Research Capital (TRC), an estimated $1.6K sold.
Based on aggregated 13F filings for Q2 2015.